US Regulatory Roundup, November 2018: Press Scrutiny, FDA Reforms And The Midterms
Executive Summary
The global investigative journalism spotlight on the medtech space had major impact at the end of November and now underlie discussions of FDA reforms, even if the agency was already working on them. Meanwhile, there was a US midterm election in November. Here's the most popular US regulation and policy stories from last month.